Pharma IP Circle

A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions

Wednesday, May 6, 2020

Zoledronic acid/ Neridronic acid - USA

›
PGR decision: May 05, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...
Friday, May 1, 2020

Sitagliptin - CJEU

›
On Apr 30, 2020, The Court of Justice of the European Union (CJEU) has handed down its decision in Royalty Pharma case on interpretation ...
Tuesday, April 28, 2020

Bendamustine - USA

›
On Apr 27, 2020, Delaware court found Eagle pharmaceuticals patents valid & infringed by ANDA filers. Plaintiffs (Teva, Cephalon ...

Rituximab – USA

›
On Apr. 27, 2020, Federal Circuit dismissed Pfizer’s appeal for lack of standing as it failed to establish that it was suffering a cogn...
Sunday, April 26, 2020

Fosaprepitant - USA

›
IPR decision: Apr. 20, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...
Friday, April 24, 2020

Fingolimod – USA

›
On Apr. 23, 2020, Federal Circuit dismissed Argentum’s appeal for lack of standing without reaching merit of the case. Petitioners su...
Wednesday, April 22, 2020

Dimethyl fumarate /Monomethyl fumarate – USA

›
On Apr. 21, 2020, Federal Circuit affirmed Delaware district court’s decision and found Banner’s 505(b)2 product containing monomethyl fum...
Friday, April 17, 2020

Tiotropium bromide - USA

›
Claim Construction (District of New Jersey): Apr. 16 2020 [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDING...
Thursday, April 9, 2020

Methylnaltrexone - USA

›
On Apr. 08, 2020, Federal Circuit reversed district court’s summary judgment decision of non-obviousness & remanded case back for fur...
Saturday, April 4, 2020

Epinephrine – USA

›
On March 31, 2020, Delaware district court found epinephrine composition patent invalid & not infringed by Hospira’s 505(b)2 produc...
‹
›
Home
View web version

Mahendraa

Mahendraa
View my complete profile
Powered by Blogger.